WHO ICTRP trial
Efficacy and safety of high dose glucocorticosteroid treatment for idiopathic…
DRKS00010738 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00010738 |
|---|---|
| Public title | Efficacy and safety of high dose glucocorticosteroid treatment for idiopathic sudden sensorineural hearing loss |
| Scientific title | Efficacy and safety of high dose glucocorticosteroid treatment for idiopathic sudden sensorineural hearing loss - HODOKORT |
| Primary sponsor | Martin-Luther-Universität Halle-Wittenberg |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Germany |
| Conditions | H91;Other hearing loss |
| Interventions | Group 1: Prednisolone, 250 mg/day i.v., for 5 days (+ Placebo p.o. 10 days) Group 2: Dexamethasone, 40 mg/day p.o., for 5 days (+ Placebo i.v. 5 days/ p.o. 5 days) Group 3: Prednisolone, 60 mg/day p.o., für 5 days & Prednisolone in tapering… |
| Registration date | Jul 15, 2016 |
| Target size | 312 |
| Secondary IDs | 2015-002602-36 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: